The latest thought leadership from our expert teams

Active filters (1)
細胞治療にかかる費用や時間の負担は減らせるのか?
Opinion

Can cell therapy become cheaper and easier?

9th Nov 2021

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

  • Bioinnovation
  • Human factors
PureSentry:リアルタイムコンタミネーション検出が細胞治療にもたらす変革
Whitepaper

PureSentry: Can real-time contamination detection transform cell therapy manufacture?

9th Nov 2021

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

  • Bioinnovation
  • Human factors
  • Physical sciences
Webinar

Miniature active implants – the key area for innovation in next-generation drug delivery

29th Oct 2021

Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are key area for innovation in next-generation drug delivery.

  • Digital health
  • Human factors
Webinar

Medtech Connect: Beyond COVID - investigating and innovating for the next generation

29th Oct 2021

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

  • Digital health
  • Strategic advice
Opinion

Neuropathy screening from diabetic retinopathy images – a deep learning breakthrough

26th Oct 2021

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

  • AI & Analytics
  • Digital health
Webinar

IPAC-RS Webinar: What is a digital biomarker and why is it important?

1st Oct 2021

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

  • Digital health
  • Human factors
Opinion

Pathology: time to join the digital world?

22nd Sep 2021

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

  • Digital health
  • Human factors
Webinar

Europe as an innovation powerhouse in ophthalmology

5th Aug 2021

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

  • Bioinnovation
  • Human factors
  • Physical sciences
Opinion

The insider’s view

2nd Aug 2021

What is it really like to work at Cambridge Consultants? Here, three senior colleagues look back on their time at the company and the experience of working here.

  • Digital service innovation
  • Embedded software
  • Human factors
  • Project management
  • Radio systems
Opinion

Our sustainable materials database is enabling innovation in the drive to net zero

10th Jun 2021

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Sustainability
Opinion

Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing

8th Jun 2021

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

  • Bioinnovation
Opinion

Miniature active implants – the key area for innovation in next-generation drug delivery

2nd Jun 2021

Innovation in drug delivery devices has evolved at a constant pace for 30 years. But what's next? Our belief is that we sit on the cusp of a decade of innovation and commercial opportunity in active implants.

  • Digital health
  • Human factors
  • User Experience (UX)